Cardiac/cardiovascular drug NOS, adverse effect: Difference between revisions
Ttenbergen (talk | contribs) mNo edit summary |
Ttenbergen (talk | contribs) |
||
| Line 15: | Line 15: | ||
== Additional Info == | == Additional Info == | ||
{{Discuss | question =*Is this the code we use for Amiodarone lung? --[[User:LKolesar|LKolesar]] 14:15, 2019 January 23 (CST) | {{Discuss | question =*Is this the code we use for Amiodarone lung? --[[User:LKolesar|LKolesar]] 14:15, 2019 January 23 (CST) | ||
** nope, as listed on old dx [[Amiodarone Lung]], use [[Interstitial lung disease, drug-induced (acute or chronic)]]. Please delete the comment once you have reviewed it.Ttenbergen 09:38, 2019 January 24 (CST) }} | ** nope, as listed on old dx [[Amiodarone Lung]] and in [[Interstitial lung disease, drug-induced (acute or chronic)]], use [[Interstitial lung disease, drug-induced (acute or chronic)]]. Please delete the comment once you have reviewed it.Ttenbergen 09:38, 2019 January 24 (CST) }} | ||
*This code is for adverse effect of any cardiac drug used appropriately | *This code is for adverse effect of any cardiac drug used appropriately | ||